Pharmaceutical Compounding

Year: 2014

Resolution Number: 49

Action Taken: Approved as Amended

Status:

Author(s): David E. Hammond, MD

Sponsor: Domenic R. Federico, MD

On behalf of:

Committee: D (Public Health)

Resolved Section(s):
RESOLVED: That MSMS works with LARA and other interested parties to ensure quality and safety of compounded prescriptions while not limiting physician access to needed compounds for patients; and be it furtherRESOLVED: That MSMS support a reasonable and accurate track and trace system of compounded products to provide an added safeguard to enable appropriate investigation of any identified injury or danger to patients.

Fiscal Note: NULL

Resolution: View PDF for Pharmaceutical Compounding

For More Information, Contact:

Colin Ford , Senior Director
State and Federal Government Relations
517-336-5736
cford@msms.org